Published in J Med Genet on November 14, 2006
Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature (2009) 5.37
Mutation of the RAD51C gene in a Fanconi anemia-like disorder. Nat Genet (2010) 3.57
Mutations in ERCC4, encoding the DNA-repair endonuclease XPF, cause Fanconi anemia. Am J Hum Genet (2013) 2.15
Hypomorphic mutations in the gene encoding a key Fanconi anemia protein, FANCD2, sustain a significant group of FA-D2 patients with severe phenotype. Am J Hum Genet (2007) 1.67
Diagnosis of Fanconi anemia in patients with bone marrow failure. Haematologica (2009) 1.25
Origin, functional role, and clinical impact of Fanconi anemia FANCA mutations. Blood (2011) 1.18
Lentiviral-mediated genetic correction of hematopoietic and mesenchymal progenitor cells from Fanconi anemia patients. Mol Ther (2009) 1.07
Targeted gene therapy and cell reprogramming in Fanconi anemia. EMBO Mol Med (2014) 0.95
Fanconi anemia signaling network regulates the spindle assembly checkpoint. J Clin Invest (2013) 0.92
AluY-mediated germline deletion, duplication and somatic stem cell reversion in UBE2T defines a new subtype of Fanconi anemia. Hum Mol Genet (2015) 0.91
Bcr/Abl interferes with the Fanconi anemia/BRCA pathway: implications in the chromosomal instability of chronic myeloid leukemia cells. PLoS One (2010) 0.81
Dysfunctional telomeres in primary cells from Fanconi anemia FANCD2 patients. Genome Integr (2012) 0.80
Inhibitory effects of marine-derived DNA-binding anti-tumour tetrahydroisoquinolines on the Fanconi anaemia pathway. Br J Pharmacol (2013) 0.78
Loss of Faap20 Causes Hematopoietic Stem and Progenitor Cell Depletion in Mice Under Genotoxic Stress. Stem Cells (2015) 0.75
A 15-year-old girl with pancytopenia and congenital defects. Ann Saudi Med (2009) 0.75
Identification of the breast cancer susceptibility gene BRCA2. Nature (1996) 17.14
Biallelic inactivation of BRCA2 in Fanconi anemia. Science (2002) 9.31
Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol Cell (2001) 8.99
The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J. Nat Genet (2005) 4.92
A novel ubiquitin ligase is deficient in Fanconi anemia. Nat Genet (2003) 4.79
A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M. Nat Genet (2005) 4.57
The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia. Nat Genet (2005) 4.13
Molecular pathogenesis of Fanconi anemia: recent progress. Blood (2006) 3.76
Cloning of cDNAs for Fanconi's anaemia by functional complementation. Nature (1992) 2.97
X-linked inheritance of Fanconi anemia complementation group B. Nat Genet (2004) 2.86
Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA. Nat Genet (1996) 2.36
Positional cloning of a novel Fanconi anemia gene, FANCD2. Mol Cell (2001) 2.33
The health of the Roma people: a review of the published literature. J Epidemiol Community Health (2000) 2.30
The Fanconi anaemia group G gene FANCG is identical with XRCC9. Nat Genet (1998) 1.99
International Fanconi Anemia Registry: relation of clinical symptoms to diepoxybutane sensitivity. Blood (1989) 1.96
Heterogeneity in Fanconi anemia: evidence for 2 new genetic subtypes. Blood (2003) 1.71
The Fanconi anaemia gene FANCF encodes a novel protein with homology to ROM. Nat Genet (2000) 1.64
Somatic mosaicism in Fanconi anemia: evidence of genotypic reversion in lymphohematopoietic stem cells. Proc Natl Acad Sci U S A (2001) 1.62
A novel diagnostic screen for defects in the Fanconi anemia pathway. Blood (2002) 1.54
Isolation of a cDNA representing the Fanconi anemia complementation group E gene. Am J Hum Genet (2000) 1.51
Reverse mosaicism in Fanconi anemia: natural gene therapy via molecular self-correction. Cytogenet Genome Res (2002) 1.49
A rapid method for retrovirus-mediated identification of complementation groups in Fanconi anemia patients. Mol Ther (2005) 1.48
Heterogeneous spectrum of mutations in the Fanconi anaemia group A gene. Eur J Hum Genet (1999) 1.36
Phenotypic correction of primary Fanconi anemia T cells with retroviral vectors as a diagnostic tool. Exp Hematol (2002) 1.31
Detection of somatic mosaicism and classification of Fanconi anemia patients by analysis of the FA/BRCA pathway. Blood (2004) 1.18
Inducibility of nuclear Rad51 foci after DNA damage distinguishes all Fanconi anemia complementation groups from D1/BRCA2. Mutat Res (2005) 1.15
Fanconi anaemia in Italy: high prevalence of complementation group A in two geographic clusters. Hum Genet (1996) 1.06
A common founder mutation in FANCA underlies the world's highest prevalence of Fanconi anemia in Gypsy families from Spain. Blood (2004) 1.05
Fanconi anemia in Tunisia: high prevalence of group A and identification of new FANCA mutations. J Hum Genet (2003) 0.97
Molecular cross-talk among chromosome fragility syndromes. Genes Dev (2004) 0.96
Mutations of the Fanconi anemia group A gene (FAA) in Italian patients. Am J Hum Genet (1997) 0.93
A simplified approach to improve the efficiency and safety of ex vivo hematopoietic gene therapy in fanconi anemia patients. Hum Gene Ther (2006) 0.84
Subtyping of Fanconi anemia patients: implications for clinical management. Blood (2003) 0.81
53BP1 inhibits homologous recombination in Brca1-deficient cells by blocking resection of DNA breaks. Cell (2010) 8.70
Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene. Nat Genet (2010) 5.48
Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature (2009) 5.37
Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer. Nat Genet (2006) 5.12
A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Blood (2002) 4.59
The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia. Nat Genet (2005) 4.13
Mutations in the pericentrin (PCNT) gene cause primordial dwarfism. Science (2008) 4.04
Identification of early replicating fragile sites that contribute to genome instability. Cell (2013) 3.99
New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge. J Clin Oncol (2012) 3.88
SLX4, a coordinator of structure-specific endonucleases, is mutated in a new Fanconi anemia subtype. Nat Genet (2011) 3.74
Mutations of the SLX4 gene in Fanconi anemia. Nat Genet (2011) 3.60
Mutation of the RAD51C gene in a Fanconi anemia-like disorder. Nat Genet (2010) 3.57
Identification of novel cytogenetic markers with prognostic significance in a series of 968 patients with primary myelodysplastic syndromes. Haematologica (2005) 3.24
A chromatin-wide transition to H4K20 monomethylation impairs genome integrity and programmed DNA rearrangements in the mouse. Genes Dev (2008) 3.16
Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease. Stem Cells (2006) 3.02
Identification of the Fanconi anemia complementation group I gene, FANCI. Cell Oncol (2007) 2.50
FANCI is a second monoubiquitinated member of the Fanconi anemia pathway. Nat Struct Mol Biol (2007) 2.47
A histone-fold complex and FANCM form a conserved DNA-remodeling complex to maintain genome stability. Mol Cell (2010) 2.36
BRCA1 functions independently of homologous recombination in DNA interstrand crosslink repair. Mol Cell (2012) 2.21
Mutations in ERCC4, encoding the DNA-repair endonuclease XPF, cause Fanconi anemia. Am J Hum Genet (2013) 2.15
Lightening up the UV response by identification of the arylhydrocarbon receptor as a cytoplasmatic target for ultraviolet B radiation. Proc Natl Acad Sci U S A (2007) 2.08
FAAP100 is essential for activation of the Fanconi anemia-associated DNA damage response pathway. EMBO J (2007) 2.00
Germline mutations in BRCA2: shared genetic susceptibility to breast cancer, early onset leukemia, and Fanconi anemia. Blood (2004) 1.67
Hypomorphic mutations in the gene encoding a key Fanconi anemia protein, FANCD2, sustain a significant group of FA-D2 patients with severe phenotype. Am J Hum Genet (2007) 1.67
A randomized, double-blind, multicenter study of caspofungin versus liposomal amphotericin B for empiric antifungal therapy in pediatric patients with persistent fever and neutropenia. Pediatr Infect Dis J (2010) 1.66
Histone H2AX and Fanconi anemia FANCD2 function in the same pathway to maintain chromosome stability. EMBO J (2007) 1.65
Genotype-phenotype correlations in Fanconi anemia. Mutat Res (2009) 1.65
Nosocomial infections among pediatric hematology/oncology patients: results of a prospective incidence study. Am J Infect Control (2004) 1.60
Cytogenetic risk stratification in chronic myelomonocytic leukemia. Haematologica (2010) 1.60
Comparison of three retroviral vector systems for transduction of nonobese diabetic/severe combined immunodeficiency mice repopulating human CD34+ cord blood cells. Hum Gene Ther (2003) 1.58
Influence of genetic polymorphisms on the risk of developing leukemia and on disease progression. Leuk Res (2006) 1.54
Human RAD50 deficiency in a Nijmegen breakage syndrome-like disorder. Am J Hum Genet (2009) 1.54
Comparison of intensive chemotherapy, allogeneic, or autologous stem-cell transplantation as postremission treatment for children with very high risk acute lymphoblastic leukemia: PETHEMA ALL-93 Trial. J Clin Oncol (2007) 1.53
Disruption of an EHMT1-associated chromatin-modification module causes intellectual disability. Am J Hum Genet (2012) 1.51
A rapid method for retrovirus-mediated identification of complementation groups in Fanconi anemia patients. Mol Ther (2005) 1.48
Delayed diagnosis and complications of Fanconi anaemia at advanced age--a paradigm. Br J Haematol (2006) 1.48
Report from the in vitro micronucleus assay working group. Mutat Res (2003) 1.47
Pandemic influenza A (2009 H1N1) in children with acute lymphoblastic leukaemia. Br J Haematol (2010) 1.46
[Guidelines for the treatment of Invasive Candidiasis and other yeasts. Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2010 Update]. Enferm Infecc Microbiol Clin (2011) 1.46
Shared genetic susceptibility to breast cancer, brain tumors, and Fanconi anemia. J Natl Cancer Inst (2003) 1.42
Mutations in the chromatin modifier gene KANSL1 cause the 17q21.31 microdeletion syndrome. Nat Genet (2012) 1.40
Targeted next-generation sequencing of a 12.5 Mb homozygous region reveals ANO10 mutations in patients with autosomal-recessive cerebellar ataxia. Am J Hum Genet (2010) 1.40
[T-cell pediatric acute lymphoblastic leukemia: analysis of survival and prognostic factors in 4 consecutive protocols of the Spanish cooperative study group SHOP]. Med Clin (Barc) (2012) 1.39
Hematopoietic dysfunction in a mouse model for Fanconi anemia group D1. Mol Ther (2006) 1.39
Clinical and molecular characteristics of squamous cell carcinomas from Fanconi anemia patients. J Natl Cancer Inst (2008) 1.36
A novel approach to describe a U1 snRNA binding site. Nucleic Acids Res (2003) 1.35
Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia. Blood (2013) 1.32
Analysis of prototype foamy virus particle-host cell interaction with autofluorescent retroviral particles. Retrovirology (2010) 1.32
Phenotypic correction of primary Fanconi anemia T cells with retroviral vectors as a diagnostic tool. Exp Hematol (2002) 1.31
A severe form of human combined immunodeficiency due to mutations in DNA ligase IV. J Immunol (2006) 1.31
Incidence and prognostic value of FLT3 internal tandem duplication and D835 mutations in acute myeloid leukemia. Haematologica (2003) 1.30
Prognostic implications of Wilms' tumor gene (WT1) expression in patients with de novo acute myeloid leukemia. Haematologica (2004) 1.28
Prostaglandin E2 plays a key role in the immunosuppressive properties of adipose and bone marrow tissue-derived mesenchymal stromal cells. Exp Cell Res (2010) 1.24
Genetic heterogeneity among Fanconi anemia heterozygotes and risk of cancer. Cancer Res (2007) 1.24
Pregenomic RNA is required for efficient incorporation of pol polyprotein into foamy virus capsids. J Virol (2002) 1.22
The t(4;22)(q12;q11) in atypical chronic myeloid leukaemia fuses BCR to PDGFRA. Hum Mol Genet (2002) 1.22
Roles of brca2 (fancd1) in oocyte nuclear architecture, gametogenesis, gonad tumors, and genome stability in zebrafish. PLoS Genet (2011) 1.22
Mesenchymal stem/progenitor cells promote the reconstitution of exogenous hematopoietic stem cells in Fancg-/- mice in vivo. Blood (2009) 1.20
Misregulated chromosome condensation in MCPH1 primary microcephaly is mediated by condensin II. Cell Cycle (2006) 1.20
Effects of an intrahospital exercise program intervention for children with leukemia. Med Sci Sports Exerc (2007) 1.19
A ubiquitin-binding protein, FAAP20, links RNF8-mediated ubiquitination to the Fanconi anemia DNA repair network. Mol Cell (2012) 1.19
Restriction of foamy viruses by primate Trim5alpha. J Virol (2008) 1.19
Origin, functional role, and clinical impact of Fanconi anemia FANCA mutations. Blood (2011) 1.18